Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: business – Page 263

SAN FRANCISCO A company now owned by Uber last year quietly bought a small firm specializing in sensor technology used in autonomous vehicles, giving the ride services company a patent in the technology and possibly a defense against a trade secrets theft lawsuit filed against it by rival Alphabet Inc.

The chief executive of little-known Tyto Lidar LLC said in a May 2016 post on LinkedIn that the company had been sold, at the same time as he and three other executives joined Otto, according to their profiles on the online business network. Official U.S. patent data shows Otto acquired Tyto technology at the same time.

Otto, a self-driving truck startup founded by former Alphabet employees, was bought by Uber in August.

Read more

Scientists from the Universidad Carlos III de Madrid (UC3M), CIEMAT (Center for Energy, Environmental and Technological Research), Hospital General Universitario Gregorio Marañón, in collaboration with the firm BioDan Group, have presented a prototype for a 3D bioprinter that can create totally functional human skin. This skin is adequate for transplanting to patients or for use in research or the testing of cosmetic, chemical, and pharmaceutical products.

This research has recently been published in the electronic version of the scientific journal Biofabrication. In this article, the team of researchers has demonstrated, for the first time, that, using the new 3D printing technology, it is possible to produce proper human skin. One of the authors, José Luis Jorcano, professor in UC3M’s department of Bioengineering and Aerospace Engineering and head of the Mixed Unit CIEMAT/UC3M in Biomedical Engineering, points out that this skin “can be transplanted to patients or used in business settings to test chemical products, cosmetics or pharmaceutical products in quantities and with timetables and prices that are compatible with these uses.”

This new human skin is one of the first living human organs created using bioprinting to be introduced to the marketplace. It replicates the natural structure of the skin, with a first external layer, the epidermis with its stratum corneum, which acts as protection against the external environment, together with another thicker, deeper layer, the dermis. This last layer consists of fibroblasts that produce collagen, the protein that gives elasticity and mechanical strength to the skin.

Read more

A new world is coming — been waiting for a while. Glad we’re finally seeing the promotion.

As Internet-of-Things keep expanding the need for interoperability and sharing of resources become a necessity. IOTA enables companies to explore new business-2-business models by making every technological resource a potential service to be traded on an open market in real time, with no fees.

Read more

Never before have businesses been able to build billion-dollar valuations in so little time. Never before have incumbent enterprises been able to go out of business so quickly. Disruption is now commonplace, and augmented reality (AR) is emerging as yet another avenue to turn industries on their heads. But what direction will this new technology take?

AR overlays digital information on the physical world using a smartphone (think Pokémon Go) or a headset. In its simplest form, AR is simply a rectangular display floating in front of the eyes, à la Google Glass. More advanced forms will drop video game characters or useful information seamlessly onto physical objects, from homes to industrial warehouses.

While virtual reality is moving into a more commercial phase, AR is a little earlier in its development. But AR’s potential practical applications are significant. So, what’s in store for AR in the coming years?

Read more

Orginal press: http://www.prweb.com/releases/2017/02/prweb14062199.htm

Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel biologics for complex regeneration and disease reversion, and SC21 Biotech, (http://www.sc21bio.tech), a biotechnology company focused on translational therapeutic applications of autologous stem cell therapy, have announced a collaboration to focus on novel cellular reprogramming and production approaches for CCR5 Delta32 homozygous cord blood stem cells, for long-term control of HIV via transplantation.

“We are very excited about this collaboration with SC21 Biotech,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular reprogramming tools and SC21 Biotech’s translational cell therapy experience, will make for a transformational opportunity in this area of HIV disease control.”

HIV-1 infection afflicts more than 35 million people worldwide. For individuals who have access to antiretroviral therapy, these drugs can effectively suppress, but not cure, HIV-1 infection. The only documented case for an HIV/AIDS cure was a patient with HIV-1 and acute myeloid leukemia who received allogeneic hematopoietic cell transplantation from a graft that carried the HIV-resistant CCR5-Delta32 homozygous mutation. The patient has remained without any evidence of HIV infection for more than 8 years after discontinuation of antiretroviral drug therapy.

However, identifying immune matched adult CCR5- Delta32 homozygous donors for a given patients is not readily feasible in part because the prevalence is in only about 0.8%–1% of individuals of northern European descent and much less in other ethnic groups, as well as the fact that for such transplants with adult cells there needs to be a very close HLA match between donor and patient.

In contrast, cord blood that is CCR5- Delta32 homozygous provides a major advantage in that much less stringent HLA matching is required between donor and patient. However, a technological method to cost effectively and industrially scale the production of such cells has been missing.

“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Mr. Paul Collier, Managing Director of SC21 Biotech. “The ability to apply Bioquark’s cellular reprogramming tools in order to produce industrial quantities of such precious cell lines will offer a much greater global penetration of this important therapeutic modality for HIV.”

“Bioquark has spent several years studying the evolutionarily perfected ability of bioactive moieties found in ooplasms to turn back biological time and re-set cellular regulatory state” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This unique initiative is one more step in our broad translation of such natural capabilities to control the progression of human diseases.”

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

About SC21 Biotech

SC21 Biotech is a novel a biotechnology company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.

My niece shared this with me; and the 1st thing of course that came to mind was VR/ AR funerals/ ceremonials as so many including myself cannot always be there doesn’t mean we could not engage/ participate in an event like a funneral or wedding. Maybe marriage via VR is a business just like a funeral via VR could be.

MEMPHIS, Tenn. (localmemphis.com) — A funeral home off Lamar Avenue is offering a different service from its competitors. You can drive up, say your final goodbyes to your loved ones, and you don’t even have to get out the car.

Ryan Bernard, owner of R. Bernard funeral home, says he got the idea from a funeral home in California. His main goal is to make it more convenient for families who are already dealing with losing a loved one.

Bernard wants his funeral home to stand out from the rest, so his family business is offering drive-thru services.

Continue reading “Local Funeral Home Offers Drive-Thru Visitation For Families Of The Dearly Departed” | >

Hmmmm.

A private space company is suing the Defense Advanced Research Projects Agency (DARPA) for allegedly taking an idea and giving it to a foreign-owned competitor.

Orbital ATK accused DARPA, which develops military technology, of giving its business plan to repair satellites to Space Systems Loral (SSL), a company-based in California but registered as foreign-owned. Orbital ATK says handing business plans to SSL violates U.S. policy.

DARPA entered into a commercial partnership with Space Systems Loral (SSL) to take advantage of its Robotic Servicing of Geosynchronous Satellites (RSGS) program to capture, re-position, and repair satellites in orbit. DARPA plans to buy future RSGS services from SSL, despite it being a Bermuda-based company.

Continue reading “Gov’t Sued For Taking US Company’s Business Plan And Giving It To Foreigners” | >

Sharing more research conducted on Quantum Bio’s Brain to Brain communications. For all my hardware/ device friends exploring their own futures in a QC world. This was resurfaced in Jan 2017; the report itself is still relevant. Quantum Bio truly will change our device markets, IoT, and medicine/ healthcare drastically. This will be where we truly see tech and bio as one.

Want to see real convergence of tech and bio meaning no more need for smart devices, improved immunology in humans to counteract proactively disease and illness, accelerate heal times from injuries, reverse aging, etc. then you need to definitely engage Quantum bio in your work and discoveries as many have seen its potential and making changes leveraging this technology.

What you do on the Internet is nobody’s business but yours. At ProxySite.com, we stand between your web use and anyone who tries to sneak a peek at it. Instead of connecting directly to a website, let us connect to the website and send it back to you, and no one will know where you’ve been. Big Brother (or other, less ominous snoops) won’t be able to look over your shoulder and spy on you to see what you’re reading, watching or saying.

Read more

I actually had a person recently state quantum was a fad; boy were they ever wrong.

During the next ten years, quantum technologies will become part of and revolutionize our everyday lives in the form of computers, sensors, encryption, and much more—and in a way that can be difficult for us to comprehend.

Businesses will also boost both their research and development activities in this area.

“As from 2018, EU’s future flagship project, which is backed by EUR 1 billion, will focus on quantum technology, and several European countries are investing massively in the area. Innovation Fund Denmark has contributed DKK 80 million, and over the next couple of years, more funds are likely to be allocated to quantum research,” explains Ulrik Lund Andersen, Professor at DTU Physics.

Continue reading “Collaboration Prepares DTU for Quantum Future” | >